The celebrity chef will help set new quality standards as part of the government’s review of hospital food.

‘Polypills’ of generic drugs may dramatically reduce heart attacks and strokes in poor countries, a new study suggests. Some experts still aren’t enthusiastic.

The U.S. health regulator on Thursday categorized the recall of Edwards Lifesciences Corp’s Sapien 3 Ultra delivery system as extremely serious, highlighting health risks associated with its use, but the products will remain on the market.

(Reuters Health) – Nearly one third of migrants traveling through Mexico to the U.S. experience physical, psychological and/or sexual violence during their journey, a new study finds.

The U.S. Food and Drug Administration said on Thursday the recall of Edwards Lifesciences Corp’s Sapien 3 Ultra delivery system was classified as the agency’s severest, sending shares of the medical device maker down 3%.

In driving simulation tests, researchers found that yellow lenses did not improve people’s performance over clear lenses.

(Reuters Health) – Hospitals appear to be treating Medicare patients in emergency departments (EDs) and observation areas to avoid readmissions and the financial penalties associated with them, according to a new U.S. study.

The mosquito-borne virus spread through the island in 2017, but global health officials failed to sound the alarm.

It’s said to ‘cleanse’ the vagina, but for one woman, the results were not what she expected. Experts have warned against the practice and are telling women to leave their vaginas alone.

(Reuters Health) – Gender minority students in U.S. colleges and universities are four times as likely as other students to experience mental health problems, researchers say.

Medical device maker Edwards Lifesciences Corp is recalling its Sapien 3 Ultra delivery system after burst balloons during implantation led to several injuries and a death, said the U.S. Food and Drug Administration on Thursday.

Retrophin Inc said on Thursday it was discontinuing the late-stage study for its rare neurological disorder treatment after it failed to improve patients’ ability to conduct daily activities such as eating and walking, sending shares down 30%.

Backache can be debilitating and it’s often hard to figure out what’s causing it. This guide might point you in the right direction.

India’s health ministry has proposed a ban on the production and import of electronic cigarettes, documents seen by Reuters showed, potentially jeopardizing the expansion plans of big firms like Juul Labs and Philip Morris International.

(Reuters Health) – Fewer U.S. adolescents are participating in programs designed to prevent substance abuse, a study suggests.

If you managed to survive the winter without getting the flu, your immunity is on track. But beware – there are some things that might hurt your immune system without you realising it.

While CT scans are quicker, easier and more widely available than MRIs and other advanced imaging, they have a large dose of ionising radiation.

The spike in cervical screenings after Jade Goody’s diagnosis did not last long, a charity says.

Melissa Compton, who swam 220 miles along the River Severn for charity, contracted a stomach bug.

Two million older people are risking side-effects from taking multiple medications, a charity warns.

Retrophin Inc said on Thursday its treatment for a rare neurological disorder failed to meet the main goal of improving patient’s ability to conduct daily activities in a late-stage study.